Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ficorella, Corrado
LIBImAb, NCT04776655: Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB	Recruiting	3	280	Europe	Bevacizumab, Avastin, Cetuximab, Erbitux, 5-FU, 5 Fluorouracil, Irinotecan, Irinotecano, Calcium levofolinate, Levofolinic acid	Azienda Unità Sanitaria Locale Reggio Emilia, Istituto Di Ricerche Farmacologiche Mario Negri, Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale	Colorectal Cancer, Metastatic Colorectal Cancer, RAS Mutation	04/23	04/24